Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease

Detalhes bibliográficos
Autor(a) principal: Ndhlovu, L. C.
Data de Publicação: 2009
Outros Autores: Snyder-Cappione, J. E., Carvalho, Karina Inacio [UNIFESP], Leal, F. E., Loo, C. P., Bruno, F. R., Jha, A. R., Devita, D., Hasenkrug, A. M., Barbosa, H. M. R. [UNIFESP], Segurado, A. C., Nixon, D. F., Murphy, E. L., Kallas, Esper Georges [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1111/j.1365-2249.2009.04019.x
http://repositorio.unifesp.br/handle/11600/31961
Resumo: Human T lymphotropic virus type 1 (HTLV-1) infects 10-20 million people worldwide. the majority of infected individuals are asymptomatic; however, approximately 3% develop the debilitating neurological disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). There is also currently no cure, vaccine or effective therapy for HTLV-1 infection, and the mechanisms for progression to HAM/TSP remain unclear. NK T cells are an immunoregulatory T cell subset whose frequencies and effector functions are associated critically with immunity against infectious diseases. We hypothesized that NK T cells are associated with HAM/TSP progression. We measured NK T cell frequencies and absolute numbers in individuals with HAM/TSP infection from two cohorts on two continents: São Paulo, Brazil and San Francisco, CA, USA, and found significantly lower levels when compared with healthy subjects and/or asymptomatic carriers. Also, the circulating NK T cell compartment in HAM/TSP subjects is comprised of significantly more CD4(+) and fewer CD8(+) cells than healthy controls. These findings suggest that lower numbers of circulating NK T cells and enrichment of the CD4(+) NK T subset are associated with HTLV-1 disease progression.
id UFSP_7fa7a2eed1dc49cbbb6a4f4b7e43200a
oai_identifier_str oai:repositorio.unifesp.br/:11600/31961
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological diseaseCD8HTLV-1 infectioninnate immunityNK T cellsCD4Human T lymphotropic virus type 1 (HTLV-1) infects 10-20 million people worldwide. the majority of infected individuals are asymptomatic; however, approximately 3% develop the debilitating neurological disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). There is also currently no cure, vaccine or effective therapy for HTLV-1 infection, and the mechanisms for progression to HAM/TSP remain unclear. NK T cells are an immunoregulatory T cell subset whose frequencies and effector functions are associated critically with immunity against infectious diseases. We hypothesized that NK T cells are associated with HAM/TSP progression. We measured NK T cell frequencies and absolute numbers in individuals with HAM/TSP infection from two cohorts on two continents: São Paulo, Brazil and San Francisco, CA, USA, and found significantly lower levels when compared with healthy subjects and/or asymptomatic carriers. Also, the circulating NK T cell compartment in HAM/TSP subjects is comprised of significantly more CD4(+) and fewer CD8(+) cells than healthy controls. These findings suggest that lower numbers of circulating NK T cells and enrichment of the CD4(+) NK T subset are associated with HTLV-1 disease progression.Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USAUniv Calif San Francisco, Dept Lab Med, San Francisco, CA 94110 USABlood Syst Res Inst, San Francisco, CA USAUniv São Paulo, Sch Med, Div Clin Immunol & Allergy, São Paulo, BrazilUniv São Paulo, Sch Med, Dept Infect Dis, São Paulo, BrazilUniversidade Federal de São Paulo, Div Infect Dis, São Paulo, BrazilUniversidade Federal de São Paulo, Div Infect Dis, São Paulo, BrazilWeb of ScienceNational Institute of Allergy and Infectious DiseasesNational Heart Lung and Blood InstituteAIDS Research Institute of University of California San FranciscoBrazilian Program for STD and AIDSMinistry of HealthSão Paulo City Health DepartmentFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)John E. Fogarty International CenterNational Institute of Allergy and Infectious Diseases: R37AI052731National Heart Lung and Blood Institute: 2R01-HL-62235Ministry of Health: 914/BRA/3014 -UNESCO/KallasSão Paulo City Health Department: 2004-0.168.922-7/KallasFAPESP: 04/15856-9/KallasJohn E. Fogarty International Center: D43 TW00003Wiley-BlackwellUniv Calif San FranciscoBlood Syst Res InstUniversidade de São Paulo (USP)Universidade Federal de São Paulo (UNIFESP)Ndhlovu, L. C.Snyder-Cappione, J. E.Carvalho, Karina Inacio [UNIFESP]Leal, F. E.Loo, C. P.Bruno, F. R.Jha, A. R.Devita, D.Hasenkrug, A. M.Barbosa, H. M. R. [UNIFESP]Segurado, A. C.Nixon, D. F.Murphy, E. L.Kallas, Esper Georges [UNIFESP]2016-01-24T13:58:56Z2016-01-24T13:58:56Z2009-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion294-299http://dx.doi.org/10.1111/j.1365-2249.2009.04019.xClinical and Experimental Immunology. Malden: Wiley-Blackwell Publishing, Inc, v. 158, n. 3, p. 294-299, 2009.10.1111/j.1365-2249.2009.04019.x0009-9104http://repositorio.unifesp.br/handle/11600/31961WOS:000271311200006engClinical and Experimental Immunologyinfo:eu-repo/semantics/openAccesshttp://olabout.wiley.com/WileyCDA/Section/id-406071.htmlreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-06-28T09:18:23Zoai:repositorio.unifesp.br/:11600/31961Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-06-28T09:18:23Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
title Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
spellingShingle Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
Ndhlovu, L. C.
CD8
HTLV-1 infection
innate immunity
NK T cells
CD4
title_short Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
title_full Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
title_fullStr Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
title_full_unstemmed Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
title_sort Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease
author Ndhlovu, L. C.
author_facet Ndhlovu, L. C.
Snyder-Cappione, J. E.
Carvalho, Karina Inacio [UNIFESP]
Leal, F. E.
Loo, C. P.
Bruno, F. R.
Jha, A. R.
Devita, D.
Hasenkrug, A. M.
Barbosa, H. M. R. [UNIFESP]
Segurado, A. C.
Nixon, D. F.
Murphy, E. L.
Kallas, Esper Georges [UNIFESP]
author_role author
author2 Snyder-Cappione, J. E.
Carvalho, Karina Inacio [UNIFESP]
Leal, F. E.
Loo, C. P.
Bruno, F. R.
Jha, A. R.
Devita, D.
Hasenkrug, A. M.
Barbosa, H. M. R. [UNIFESP]
Segurado, A. C.
Nixon, D. F.
Murphy, E. L.
Kallas, Esper Georges [UNIFESP]
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Univ Calif San Francisco
Blood Syst Res Inst
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Ndhlovu, L. C.
Snyder-Cappione, J. E.
Carvalho, Karina Inacio [UNIFESP]
Leal, F. E.
Loo, C. P.
Bruno, F. R.
Jha, A. R.
Devita, D.
Hasenkrug, A. M.
Barbosa, H. M. R. [UNIFESP]
Segurado, A. C.
Nixon, D. F.
Murphy, E. L.
Kallas, Esper Georges [UNIFESP]
dc.subject.por.fl_str_mv CD8
HTLV-1 infection
innate immunity
NK T cells
CD4
topic CD8
HTLV-1 infection
innate immunity
NK T cells
CD4
description Human T lymphotropic virus type 1 (HTLV-1) infects 10-20 million people worldwide. the majority of infected individuals are asymptomatic; however, approximately 3% develop the debilitating neurological disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). There is also currently no cure, vaccine or effective therapy for HTLV-1 infection, and the mechanisms for progression to HAM/TSP remain unclear. NK T cells are an immunoregulatory T cell subset whose frequencies and effector functions are associated critically with immunity against infectious diseases. We hypothesized that NK T cells are associated with HAM/TSP progression. We measured NK T cell frequencies and absolute numbers in individuals with HAM/TSP infection from two cohorts on two continents: São Paulo, Brazil and San Francisco, CA, USA, and found significantly lower levels when compared with healthy subjects and/or asymptomatic carriers. Also, the circulating NK T cell compartment in HAM/TSP subjects is comprised of significantly more CD4(+) and fewer CD8(+) cells than healthy controls. These findings suggest that lower numbers of circulating NK T cells and enrichment of the CD4(+) NK T subset are associated with HTLV-1 disease progression.
publishDate 2009
dc.date.none.fl_str_mv 2009-12-01
2016-01-24T13:58:56Z
2016-01-24T13:58:56Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1111/j.1365-2249.2009.04019.x
Clinical and Experimental Immunology. Malden: Wiley-Blackwell Publishing, Inc, v. 158, n. 3, p. 294-299, 2009.
10.1111/j.1365-2249.2009.04019.x
0009-9104
http://repositorio.unifesp.br/handle/11600/31961
WOS:000271311200006
url http://dx.doi.org/10.1111/j.1365-2249.2009.04019.x
http://repositorio.unifesp.br/handle/11600/31961
identifier_str_mv Clinical and Experimental Immunology. Malden: Wiley-Blackwell Publishing, Inc, v. 158, n. 3, p. 294-299, 2009.
10.1111/j.1365-2249.2009.04019.x
0009-9104
WOS:000271311200006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Clinical and Experimental Immunology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
http://olabout.wiley.com/WileyCDA/Section/id-406071.html
eu_rights_str_mv openAccess
rights_invalid_str_mv http://olabout.wiley.com/WileyCDA/Section/id-406071.html
dc.format.none.fl_str_mv 294-299
dc.publisher.none.fl_str_mv Wiley-Blackwell
publisher.none.fl_str_mv Wiley-Blackwell
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268376159092736